Evidence map›Paper›PMID 37556007›Full record

ArticleAnnals of surgical oncology2023

Cost-Effectiveness of [

Karen Y Choi, Qiang Hao, Kathryn Carlisle, Christopher S Hollenbeak, Stephen Y Lai

Open access · hybridAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Karen Y ChoiPenn State College of Medicine, Hershey Medical Center, Hershey, PA, USA. kchoi@pennstatehealth.psu.edu.
Qiang HaoDepartment of Health Policy and Administration, Penn State University, University Park, PA, USA.
Kathryn CarlislePenn State College of Medicine, Hershey Medical Center, Hershey, PA, USA.
Christopher S HollenbeakDepartment of Health Policy and Administration, Penn State University, University Park, PA, USA.
Stephen Y LaiDepartment of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pennsylvania State University · USPenn State Milton S. Hershey Medical Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral studies have demonstrated varying rates of efficacy, reliability, and sensitivity of sentinel lymph node biopsy (SLNB) in identifying occult nodal disease for early stage oral cavity squamous cell carcinoma (OCSCC) depending on the radionuclide agent utilized. No head-to-head comparison of cost or clinical outcomes of SLNB when utilizing [ PATIENTS AND

methodsA decision model of disease and treatment as a function of SLNB was created. Patients with a negative SLNB entered a Markov model of the natural history of OCSCC parameterized with published data to simulate five states of health and iterated over a 30-year time horizon. Treatment costs and quality-adjusted life-years (QALYs) for each health state were included. The incremental cost-effectiveness ratio (ICER) was then estimated using $100,000 per additional QALY as the threshold for determining cost-effectiveness.

resultsThe base case cost-effectiveness analysis suggested [

conclusionOur analysis showed that while [

Indexed as

Carcinoma, Squamous CellDextransMouth NeoplasmsRadiopharmaceuticalsSentinel Lymph Node BiopsyTechnetium Tc 99m PentetateTechnetium Tc 99m Sulfur ColloidCost-Benefit AnalysisHumansMannansMarkov ChainsNeoplasm StagingPrognosisQuality-Adjusted Life YearsDextransMannansRadiopharmaceuticalstechnetium-diethylenetriaminepentaacetic acid-mannosyl-dextranTechnetium Tc 99m PentetateTechnetium Tc 99m Sulfur Colloid

Identifiers

PMID37556007
PMCPMC10562505
OpenAlexW4385683608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.